UnitedHealth Group stock falls after dividend ex-date as Q2 2026 earnings underline margin strength

Published on 09/14/2026 at 14:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UnitedHealth Group stock closed at USD 379.09 on September 11, 2026 on the NYSE, ahead of a USD 2.32 cash dividend with an ex-dividend date of September 14, 2026. Q2 FY26 revenue of USD 112.03 billion and earnings of USD 5.48 billion marked a profit margin of 4.90 percent.

Fotorealistisches Krankenhaus-Außengebäude bei Sonnenuntergang mit Glasfassade und Fußgängern — UnitedHealth Group US91324P1021 zeigt modernes Krankenhaus im Sonnenuntergang mit Glasfassade und Besuchern, Illustration mit AI erstellt.

UnitedHealth Group Inc. stock (ISIN US91324P1021) finished the last completed trading day at USD 379.09 on the NYSE on September 11, 2026, down 2.37 percent from the prior close as the shares moved toward a USD 2.32 cash dividend with an ex-dividend date of September 14, 2026 per data on UnitedHealth Group Incorporated (UNH) from Yahoo Finance.

Dividend ex-date and recent price moves

According to Yahoo Finance data for UnitedHealth Group Incorporated (UNH), the stock closed at USD 379.09 on the NYSE on September 11, 2026, compared with a prior close of USD 388.28, implying a daily decline of 2.37 percent alongside a modest after-hours move to USD 377.42 later the same day.

The same overview notes that UnitedHealth announced a cash dividend of USD 2.32 per share with an ex-dividend date of September 14, 2026, giving the stock a dividend yield of about 2.36 percent at the latest quoted level and providing income-oriented investors with a near-term catalyst around mid-September 2026, based on the payout figures shown for UNH.

Earnings and margins in Q2 FY26

In its latest reported quarter, Q2 of fiscal year 2026, UnitedHealth Group posted revenue of USD 112.03 billion and earnings of USD 5.48 billion, corresponding to a profit margin of 4.90 percent according to the quarterly fundamentals section for UNH on Yahoo Finance, which presents GAAP revenue and earnings for Q2 FY26.

Those Q2 FY26 earnings compare with analyst estimates of USD 4.92 per share listed in the same data set, while the actual figure reached USD 6.38 per share, meaning UnitedHealth beat the consensus estimate by USD 1.46 per share in the quarter per the Q2 FY26 estimate versus actual EPS line on the Yahoo Finance page for UnitedHealth Group Incorporated (UNH).

Valuation context and fair value gap

Beyond near-term dividend and earnings momentum, valuation tools paint UnitedHealth Group stock as trading at a notable discount to intrinsic value. A recent analysis from GuruFocus on September 13, 2026 argues that UNH looks 36.0 percent undervalued versus its GF Value, stating that the company’s GF Value of USD 592.26 is 36.0 percent higher than the current market price of USD 379.09 and assigning the stock a GF Score of 80 out of 100 for overall fundamentals, as highlighted in a report by GuruFocus.

The same GuruFocus piece on September 13, 2026 notes that UNH’s trailing price-to-earnings ratio stands at 24.39 times, slightly below its five-year median P/E of 25.57 times, and that the shares offer a dividend yield of 2.36 percent supported by a three-year dividend growth rate of 10.9 percent and a payout ratio of 49 percent, suggesting room for continued distributions under its current earnings profile according to GuruFocus.

Analyst views and macro-driven pricing

On the analyst side, UBS recently reiterated its positive stance on UnitedHealth Group stock, with its analyst A.J. Rice maintaining a Buy rating and a target price of USD 490 per share for UNH as reported on September 14, 2026 by Futunn News.

A separate quantitative view from Interactive Investor’s eyeQ model on September 14, 2026 finds that macro forces such as growth, inflation and Federal Reserve policy explain 72 percent of UnitedHealth Group’s price action and that the stock has opened up a fair value gap of roughly 26 percent, with a model value of USD 477.44 versus the current share price, pointing to potential upside if macro conditions remain supportive according to Interactive Investor.

Technical signals and peer comparison

Short-term trading indicators have registered a notable move in UnitedHealth Group shares. A US stock signals summary dated September 14, 2026 observes that UNH has broken below the lower Bollinger Band, with its closing price falling under that technical threshold and several indicators such as BIAS(24), VR and WMSR shifting from neutral into oversold territory, signaling a possible reversal opportunity for technically oriented investors according to a market note on Moomoo Community.

From a peer perspective, an AltIndex stock comparison updated on September 14, 2026 shows UnitedHealth trading at USD 379.09 with a market capitalization of USD 340.27 billion and a 12-month price change of plus 6.6 percent, while assigning the stock an AI Score of 55 in the insurance industry, which positions it slightly below insurer Chubb’s score of 61 in that model according to AltIndex.

Closing price context for UnitedHealth Group stock

At a closing level of USD 379.09 on the NYSE as of September 11, 2026, UnitedHealth Group stock stands modestly above its recent daily low of USD 375.90 and below the day’s high of USD 391.90 from the September 13, 2026 trading session, while its market capitalization is around USD 340 billion based on recent portal data, leaving the shares several percent under their short-term high and, according to valuation models, well below indicated fair value ranges for long-term investors.